Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C16H13ClN2O4S |
| Molecular Weight | 364.803 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
NS(=O)(=O)C1=CC=C(N2C(=O)CC(C2=O)C3=CC=CC=C3)C(Cl)=C1
InChI
InChIKey=JUIHCCIFJCSFON-UHFFFAOYSA-N
InChI=1S/C16H13ClN2O4S/c17-13-8-11(24(18,22)23)6-7-14(13)19-15(20)9-12(16(19)21)10-4-2-1-3-5-10/h1-8,12H,9H2,(H2,18,22,23)
| Molecular Formula | C16H13ClN2O4S |
| Molecular Weight | 364.803 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Suclofenide is a benzenesulfonamide derivative patented by Geistlich, Ed., Soehne A.-G. fuer Chemische Industrie as anticonvulsant and antiepileptic agent. In preclinical models Suclofenide shows potent anticonvulsant activity against electroshock- and pentylenetetrazole-induced convulsions in mice. Sublethal toxic manifestations were drowsiness, myoclonic twitches, and diarrhea.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:00:58 GMT 2025
by
admin
on
Mon Mar 31 19:00:58 GMT 2025
|
| Record UNII |
3V0537Z59Q
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C264
Created by
admin on Mon Mar 31 19:00:58 GMT 2025 , Edited by admin on Mon Mar 31 19:00:58 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID60865536
Created by
admin on Mon Mar 31 19:00:58 GMT 2025 , Edited by admin on Mon Mar 31 19:00:58 GMT 2025
|
PRIMARY | |||
|
250-111-5
Created by
admin on Mon Mar 31 19:00:58 GMT 2025 , Edited by admin on Mon Mar 31 19:00:58 GMT 2025
|
PRIMARY | |||
|
30279-49-3
Created by
admin on Mon Mar 31 19:00:58 GMT 2025 , Edited by admin on Mon Mar 31 19:00:58 GMT 2025
|
PRIMARY | |||
|
72094
Created by
admin on Mon Mar 31 19:00:58 GMT 2025 , Edited by admin on Mon Mar 31 19:00:58 GMT 2025
|
PRIMARY | |||
|
m941
Created by
admin on Mon Mar 31 19:00:58 GMT 2025 , Edited by admin on Mon Mar 31 19:00:58 GMT 2025
|
PRIMARY | Merck Index | ||
|
3833
Created by
admin on Mon Mar 31 19:00:58 GMT 2025 , Edited by admin on Mon Mar 31 19:00:58 GMT 2025
|
PRIMARY | |||
|
CHEMBL315877
Created by
admin on Mon Mar 31 19:00:58 GMT 2025 , Edited by admin on Mon Mar 31 19:00:58 GMT 2025
|
PRIMARY | |||
|
3V0537Z59Q
Created by
admin on Mon Mar 31 19:00:58 GMT 2025 , Edited by admin on Mon Mar 31 19:00:58 GMT 2025
|
PRIMARY | |||
|
100000083508
Created by
admin on Mon Mar 31 19:00:58 GMT 2025 , Edited by admin on Mon Mar 31 19:00:58 GMT 2025
|
PRIMARY | |||
|
SUB10666MIG
Created by
admin on Mon Mar 31 19:00:58 GMT 2025 , Edited by admin on Mon Mar 31 19:00:58 GMT 2025
|
PRIMARY | |||
|
C72848
Created by
admin on Mon Mar 31 19:00:58 GMT 2025 , Edited by admin on Mon Mar 31 19:00:58 GMT 2025
|
PRIMARY | |||
|
4008
Created by
admin on Mon Mar 31 19:00:58 GMT 2025 , Edited by admin on Mon Mar 31 19:00:58 GMT 2025
|
PRIMARY | |||
|
C015381
Created by
admin on Mon Mar 31 19:00:58 GMT 2025 , Edited by admin on Mon Mar 31 19:00:58 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |